Latest news
AdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMTAdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMTAdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:17:00 GMTAdAlta Completes US$1 Million EW-001 Milestone Payment, Advances CAR-T Manufacturing to Australia - KalkineKalkine · Tue, 28 Jul 2026 23:41:10 GMT